KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Camillo Porta; Aristotelis Bamias; Farhad R. Danesh; Alicja Dębska-Ślizień; Maurizio Gallieni; Morie A. Gertz; Jan T. Kielstein; Petra Tesarova; Germaine Wong; Michael Cheung; David C. Wheeler; Wolfgang C. Winkelmayer; Jolanta Małyszko; Ali K. Abu-Alfa; Hatem Amer; Gernot Beutel; Jeremy Chapman; Xiaohong Chen; Jerzy Chudek; Laura Cosmai; Romano Danesi; Filippo De Stefano; Kunitoshi Iseki; Edgar A. Jaimes; Kenar D. Jhaveri; Artur Jurczyszyn; Rümeyza Kazancioğlu; Abhijat Kitchlu; Christian Kollmannsberger; Amit Lahoti; Yang Li; Manuel Macía; Takeshi Matsubara; Dionysios Mitropoulos; Eisei Noiri; Mark A. Perazella; Pierre Ronco; Mitchell H. Rosner; Maria Jose Soler Romeo; Ben Sprangers; Walter M. Stadler; Paul E. Stevens; Tesař ladimír Tesař; Verônica Torres da Costa e Silva; David H. Vesole; Anitha Vijayan; Ondřej Viklický; Biruh T. Workeneh; Motoko Yanagita; Elena Zakharova

doi:10.1016/j.kint.2020.06.046

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Camillo Porta, Aristotelis Bamias, Farhad R. Danesh, Alicja Dębska-Ślizień, Maurizio Gallieni, Morie A. Gertz, Jan T. Kielstein, Petra Tesarova, Germaine Wong, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Jolanta Małyszko, Ali K. Abu-Alfa, Hatem Amer, Gernot Beutel, Jeremy Chapman, Xiaohong Chen, Jerzy Chudek, Laura CosmaiRomano Danesi, Filippo De Stefano, Kunitoshi Iseki, Edgar A. Jaimes, Kenar D. Jhaveri, Artur Jurczyszyn, Rümeyza Kazancioğlu, Abhijat Kitchlu, Christian Kollmannsberger, Amit Lahoti, Yang Li, Manuel Macía, Takeshi Matsubara, Dionysios Mitropoulos, Eisei Noiri, Mark A. Perazella, Pierre Ronco, Mitchell H. Rosner, Maria Jose Soler Romeo, Ben Sprangers, Walter M. Stadler, Paul E. Stevens, Tesař ladimír Tesař, Verônica Torres da Costa e Silva, David H. Vesole, Anitha Vijayan, Ondřej Viklický, Biruh T. Workeneh, Motoko Yanagita, Elena Zakharova

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.

Original language	English (US)
Pages (from-to)	1108-1119
Number of pages	12
Journal	Kidney international
Volume	98
Issue number	5
DOIs	https://doi.org/10.1016/j.kint.2020.06.046
State	Published - Nov 2020

Keywords

glomerular filtration rate
nephrotoxicity
oncology
renal cell carcinoma

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.kint.2020.06.046

Cite this

Porta, C., Bamias, A., Danesh, F. R., Dębska-Ślizień, A., Gallieni, M., Gertz, M. A., Kielstein, J. T., Tesarova, P., Wong, G., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., Małyszko, J., Abu-Alfa, A. K., Amer, H., Beutel, G., Chapman, J., Chen, X., Chudek, J., ... Zakharova, E. (2020). KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer. Kidney international, 98(5), 1108-1119. https://doi.org/10.1016/j.kint.2020.06.046

Porta, C, Bamias, A, Danesh, FR, Dębska-Ślizień, A, Gallieni, M, Gertz, MA, Kielstein, JT, Tesarova, P, Wong, G, Cheung, M, Wheeler, DC, Winkelmayer, WC, Małyszko, J, Abu-Alfa, AK, Amer, H, Beutel, G, Chapman, J, Chen, X, Chudek, J, Cosmai, L, Danesi, R, De Stefano, F, Iseki, K, Jaimes, EA, Jhaveri, KD, Jurczyszyn, A, Kazancioğlu, R, Kitchlu, A, Kollmannsberger, C, Lahoti, A, Li, Y, Macía, M, Matsubara, T, Mitropoulos, D, Noiri, E, Perazella, MA, Ronco, P, Rosner, MH, Soler Romeo, MJ, Sprangers, B, Stadler, WM, Stevens, PE, ladimír Tesař, T, Torres da Costa e Silva, V, Vesole, DH, Vijayan, A, Viklický, O, Workeneh, BT, Yanagita, M & Zakharova, E 2020, 'KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer', Kidney international, vol. 98, no. 5, pp. 1108-1119. https://doi.org/10.1016/j.kint.2020.06.046

@article{834d72642c2c4b4693de145178c11470,

title = "KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer",

abstract = "The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.",

keywords = "glomerular filtration rate, nephrotoxicity, oncology, renal cell carcinoma",

author = "Camillo Porta and Aristotelis Bamias and Danesh, {Farhad R.} and Alicja D{\c e}bska-{\'S}lizie{\'n} and Maurizio Gallieni and Gertz, {Morie A.} and Kielstein, {Jan T.} and Petra Tesarova and Germaine Wong and Michael Cheung and Wheeler, {David C.} and Winkelmayer, {Wolfgang C.} and Jolanta Ma{\l}yszko and Abu-Alfa, {Ali K.} and Hatem Amer and Gernot Beutel and Jeremy Chapman and Xiaohong Chen and Jerzy Chudek and Laura Cosmai and Romano Danesi and {De Stefano}, Filippo and Kunitoshi Iseki and Jaimes, {Edgar A.} and Jhaveri, {Kenar D.} and Artur Jurczyszyn and R{\"u}meyza Kazancioğlu and Abhijat Kitchlu and Christian Kollmannsberger and Amit Lahoti and Yang Li and Manuel Mac{\'i}a and Takeshi Matsubara and Dionysios Mitropoulos and Eisei Noiri and Perazella, {Mark A.} and Pierre Ronco and Rosner, {Mitchell H.} and {Soler Romeo}, {Maria Jose} and Ben Sprangers and Stadler, {Walter M.} and Stevens, {Paul E.} and {ladim{\'i}r Tesa{\v r}}, Tesa{\v r} and {Torres da Costa e Silva}, Ver{\^o}nica and Vesole, {David H.} and Anitha Vijayan and Ond{\v r}ej Viklick{\'y} and Workeneh, {Biruh T.} and Motoko Yanagita and Elena Zakharova",

note = "Publisher Copyright: {\textcopyright} 2020 Kidney Disease:Improving Global Outcomes (KDIGO)",

year = "2020",

month = nov,

doi = "10.1016/j.kint.2020.06.046",

language = "English (US)",

volume = "98",

pages = "1108--1119",

journal = "Kidney international",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - KDIGO Controversies Conference on onco-nephrology

T2 - understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

AU - Porta, Camillo

AU - Bamias, Aristotelis

AU - Danesh, Farhad R.

AU - Dębska-Ślizień, Alicja

AU - Gallieni, Maurizio

AU - Gertz, Morie A.

AU - Kielstein, Jan T.

AU - Tesarova, Petra

AU - Wong, Germaine

AU - Cheung, Michael

AU - Wheeler, David C.

AU - Winkelmayer, Wolfgang C.

AU - Małyszko, Jolanta

AU - Abu-Alfa, Ali K.

AU - Amer, Hatem

AU - Beutel, Gernot

AU - Chapman, Jeremy

AU - Chen, Xiaohong

AU - Chudek, Jerzy

AU - Cosmai, Laura

AU - Danesi, Romano

AU - De Stefano, Filippo

AU - Iseki, Kunitoshi

AU - Jaimes, Edgar A.

AU - Jhaveri, Kenar D.

AU - Jurczyszyn, Artur

AU - Kazancioğlu, Rümeyza

AU - Kitchlu, Abhijat

AU - Kollmannsberger, Christian

AU - Lahoti, Amit

AU - Li, Yang

AU - Macía, Manuel

AU - Matsubara, Takeshi

AU - Mitropoulos, Dionysios

AU - Noiri, Eisei

AU - Perazella, Mark A.

AU - Ronco, Pierre

AU - Rosner, Mitchell H.

AU - Soler Romeo, Maria Jose

AU - Sprangers, Ben

AU - Stadler, Walter M.

AU - Stevens, Paul E.

AU - ladimír Tesař, Tesař

AU - Torres da Costa e Silva, Verônica

AU - Vesole, David H.

AU - Vijayan, Anitha

AU - Viklický, Ondřej

AU - Workeneh, Biruh T.

AU - Yanagita, Motoko

AU - Zakharova, Elena

PY - 2020/11

Y1 - 2020/11

N2 - The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.

AB - The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues in the setting of malignancy can worsen patient outcomes and diminish the adequacy of anticancer treatments. In addition, the oncology treatment landscape is changing rapidly, and data on tolerability of novel therapies in patients with CKD are often lacking. Caring for oncology patients has become more specialized and interdisciplinary, currently requiring collaboration among specialists in nephrology, medical oncology, critical care, clinical pharmacology/pharmacy, and palliative care, in addition to surgeons and urologists. To identify key management issues in nephrology relevant to patients with malignancy, KDIGO (Kidney Disease: Improving Global Outcomes) assembled a global panel of multidisciplinary clinical and scientific expertise for a controversies conference on onco-nephrology in December 2018. This report covers issues related to kidney impairment and solid organ malignancies as well as management and treatment of kidney cancer. Knowledge gaps, areas of controversy, and research priorities are described.

KW - glomerular filtration rate

KW - nephrotoxicity

KW - oncology

KW - renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85093980957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85093980957&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2020.06.046

DO - 10.1016/j.kint.2020.06.046

M3 - Article

C2 - 33126977

AN - SCOPUS:85093980957

SN - 0085-2538

VL - 98

SP - 1108

EP - 1119

JO - Kidney international

JF - Kidney international

IS - 5

ER -

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this